首页 工具
登录

搜索结果

Search Results for "Influenza HA (110-119)"
Targets Recommended: Others

2

抑制剂 & 化合物

102

化合物库

5

TargetMol 试剂盒

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

Cat. No. Product Name
CL0046 5-HT Receptor antagonist/agonist kit

L1710 抗COVID-19化合物库

1160 compounds
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents;
DP1100 钠离子通道阻滞剂/拮抗剂库

L6720 抗COVID-19中药单体库

1162 compounds
A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;
CL0073 DNA synthesis inhibitor/activator kit

CL0056 CDK inhibitor kit

L7110 抗高血压化合物库

719 compounds
719 hypertension-related small molecules for high-throughput and high-content screening.
L6730 抗病毒中药单体化合物库

270 compounds
A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.
L1700 抗病毒库

800 compounds
A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;
L8800 药物片段库

1158 compounds
1158 drug fragments,a must-have tool for FBDD;
L5610 Golden骨架库

10000 compounds
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source;
CL0058 EGFR inhibitor kit

L7100 抗肥胖化合物库

1359 compounds
A unique collection of 1359 anti-obesity compounds for high throughput and high content screening;
L1800 抗感染化合物库

2977 compounds
A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;
L5100 含氟化合物库

583 compounds
A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
DO1200 药物靶点库

DP9200 DGK抑制剂库

L8500 HIF-1化合物库

1352 compounds
A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies;
DF4500 多样性核心库Part1

VM1400 多样性核心库Part2

L6210 藏药化合物库

754 compounds
A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L7700 神经再生化合物库

529 compounds
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;
L4710 非甾体类抗炎化合物库

530 compounds
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.
L3510 甲基化化合物库

131 compounds
131 methylation-related compounds that can be used for high-throughput and high-content screening.
L1580 GPCR库Plus

338 compounds
Well-chosen 338 GPCR targeting compounds with unique structures;
L6300 药食同源库

1088 compounds
A unique collection of 1088 compounds from food as medicine for high throughput and high content screening;
L9420 外泌体相关化合物库

54 compounds
54 exosome-related compounds that can be used for high-throughput and high-content screening.
L1500 GPCR靶点分子库

1633 compounds
A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;
L2190 抗肺癌化合物库

1735 compounds
A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study;
L2191 抗乳腺癌化合物库

1965 compounds
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;
L2130 抗癌细胞代谢库

1280 compounds
A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
CL0139 ROS inhibitor kit

L4500 抗真菌库

253 compounds
A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.
L6220 蒙药化合物库

960 compounds
A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L2180 抗肿瘤库Plus

1468 compounds
Well-chosen 1468 anti-tumor compounds with unique structures;
L9410 共价抑制剂库

941 compounds
A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc.
L5800 药物代谢杂质库

200 compounds
A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L7300 钾通道分子库

160 compounds
A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening;
L2620 神经退行性疾病化合物库

1622 compounds
A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS;
L9700 内质网应激化合物库

193 compounds
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L9830 抗帕金森病化合物库

908 compounds
A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L9200 药物功能重定位化合物库

4240 compounds
A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L8110 细胞重编程化合物库

1840 compounds
A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L6810 中药单体化合物库

2688 compounds
A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;
L9230 ReFRAME 相关化合物库

3274 compounds
A unique collection of 3274 compounds for high-throughput screening and high-content screening,
L7860 Mini片段亲电杂环化合物库

369 compounds
369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library
L8400 血液病分子库

524 compounds
A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L7830 高溶解性片段药效团化合物库

985 compounds
High Solubility Pharmacophore Fragment library contains 985 fragment small molecules.
L6120 黄酮类天然产物库

477 compounds
A unique collection of 477 flavonoids can be used for high throughput and high content screening;
L2540 肠道微生物代谢化合物库

352 compounds
A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS;
L2520 糖代谢化合物库

708 compounds
708 glycometabolism-related comounds, can be used for HTS and HCT;
L1000 上市药物库

2863 compounds
A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L5700 精选片段库

246 compounds
A unique collection of 246 fragment-like small molecules for FBDD;
L6010 天然产物库

3720 compounds
A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS);
L4510 抗寄生虫库

336 compounds
336 well-chosen unique anti-parasitic small molecules;
L4660 神经疾病库Plus

1246 compounds
Well-chosen 1246 compounds with unique structures targeting nervous system;
L3900 DNA 损伤和修复分子库

937 compounds
A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);
NY1000 天然产物衍生物库

4000 compounds
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).
L9400 PPI抑制剂库

260 compounds
A unique collection of 260 PPI-related compounds for drug screening;
L2000 抑制剂库

7618 compounds
A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1010 FDA上市及药典收录分子库

3158 compounds
3158个上市及药典分子集合,可用于高通量筛选和高内涵筛选;
L6800 中国药典收录天然产物库

2070 compounds
A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;
L3200 自噬库

1248 compounds
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L3980 DNA损伤/修复库Plus

667 compounds
Well-chosen 667 compounds with unique structures targeting DNA damage & repair;
L6030 天然产物衍生物虚筛化合物库

L1200 表观遗传库

960 compounds
Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L2192 抗胰腺癌化合物库

2267 compounds
A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS;
L3600 细胞因子抑制剂库

613 compounds
A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;
L1610 FDA 上市激酶抑制剂库

280 compounds
Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research.
L2521 糖酵解化合物库

560 compounds
560 glycolysis-related active compounds for high-throughput and high-content screening.
L8600 泛素化化合物库

214 compounds
A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening;
L8700 铁死亡化合物库

800 compounds
A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study;
L9850 口服活性化合物库

2484 compounds
A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening.
L2800 5-羟色胺分子库

275 compounds
A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening;
L8710 铜死亡化合物库

411 compounds
TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases.
L1120 AMPK靶向分子库

64 compounds
64 well-chosen unique AMPK-targeted small molecules;
L4800 血管生成库

1370 compounds
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L9210 儿童药物库

1015 compounds
A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening.
L6110 生物碱类天然产物库

468 compounds
A unique collection of 468 natural alkaloids can be used for high throughput and high content screening;
L7500 凝血与抗凝化合物库

154 compounds
A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);
L9860 抗抑郁症化合物库

1181 compounds
1181 compounds associated with depression that can be used for high-throughput and high-content screening
L2600 神经信号分子库

2011 compounds
A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L9000 细胞凋亡化合物库

1796 compounds
A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L6700 抗癌天然产物库

1800 compounds
A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2500 人内源代谢化合物库

1400 compounds
A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening;
L2140 癌细胞分化化合物库

413 compounds
A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening;
L4010 已知活性化合物库

20980 compounds
A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L2194 抗结直肠癌化合物库

1565 compounds
1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L6200 瑶药化合物库

225 compounds
A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening.
L2510 脂代谢化合物库

496 compounds
A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L9600 多肽分子库

533 compounds
533 peptides can be used in peptide drug development and signaling transduction and mechanism study;
L2610 神经递质受体化合物库

1513 compounds
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening;
L4700 免疫/炎症分子化合物库

3483 compounds
A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening.
L4600 植物来源化合物库

3076 compounds
A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L6000 高通量筛选天然产物库

4320 compounds
A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen
L6400 海洋天然产物库

94 compounds
A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS);
L2170 肿瘤免疫治疗小分子化合物库

454 compounds
A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening;
L9840 抗阿尔茨海默症化合物库

1040 compounds
A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.
L9300 大环化合物库

216 compounds
216种活性已知的大环化合物,用于高通量、高内涵筛选;
L6740 抗结直肠癌中药单体化合物库

386 compounds
A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.
DC1010 特权片段注释化合物库-GPCR Family A

DP1300 h-TERT靶向化合物库

化合物库

5-HT Receptor antagonist/agonist kit
CL0046
Compounds: 0
抗COVID-19化合物库
L1710
Compounds: 1160
钠离子通道阻滞剂/拮抗剂库
DP1100
Compounds: 0
抗COVID-19中药单体库
L6720
Compounds: 1162
DNA synthesis inhibitor/activator kit
CL0073
Compounds: 0
CDK inhibitor kit
CL0056
Compounds: 0
抗高血压化合物库
L7110
Compounds: 719
抗病毒中药单体化合物库
L6730
Compounds: 270
抗病毒库
L1700
Compounds: 800
药物片段库
L8800
Compounds: 1158
Golden骨架库
L5610
Compounds: 10000
EGFR inhibitor kit
CL0058
Compounds: 0
抗肥胖化合物库
L7100
Compounds: 1359
抗感染化合物库
L1800
Compounds: 2977
含氟化合物库
L5100
Compounds: 583
药物靶点库
DO1200
Compounds: 0
DGK抑制剂库
DP9200
Compounds: 0
HIF-1化合物库
L8500
Compounds: 1352
多样性核心库Part1
DF4500
Compounds: 0
多样性核心库Part2
VM1400
Compounds: 0
藏药化合物库
L6210
Compounds: 754
神经再生化合物库
L7700
Compounds: 529
非甾体类抗炎化合物库
L4710
Compounds: 530
甲基化化合物库
L3510
Compounds: 131
GPCR库Plus
L1580
Compounds: 338
药食同源库
L6300
Compounds: 1088
外泌体相关化合物库
L9420
Compounds: 54
GPCR靶点分子库
L1500
Compounds: 1633
抗肺癌化合物库
L2190
Compounds: 1735
抗乳腺癌化合物库
L2191
Compounds: 1965
抗癌细胞代谢库
L2130
Compounds: 1280
ROS inhibitor kit
CL0139
Compounds: 0
抗真菌库
L4500
Compounds: 253
蒙药化合物库
L6220
Compounds: 960
抗肿瘤库Plus
L2180
Compounds: 1468
共价抑制剂库
L9410
Compounds: 941
药物代谢杂质库
L5800
Compounds: 200
钾通道分子库
L7300
Compounds: 160
神经退行性疾病化合物库
L2620
Compounds: 1622
内质网应激化合物库
L9700
Compounds: 193
抗帕金森病化合物库
L9830
Compounds: 908
药物功能重定位化合物库
L9200
Compounds: 4240
细胞重编程化合物库
L8110
Compounds: 1840
中药单体化合物库
L6810
Compounds: 2688
ReFRAME 相关化合物库
L9230
Compounds: 3274
Mini片段亲电杂环化合物库
L7860
Compounds: 369
血液病分子库
L8400
Compounds: 524
高溶解性片段药效团化合物库
L7830
Compounds: 985
黄酮类天然产物库
L6120
Compounds: 477
肠道微生物代谢化合物库
L2540
Compounds: 352
糖代谢化合物库
L2520
Compounds: 708
上市药物库
L1000
Compounds: 2863
精选片段库
L5700
Compounds: 246
天然产物库
L6010
Compounds: 3720
抗寄生虫库
L4510
Compounds: 336
神经疾病库Plus
L4660
Compounds: 1246
DNA 损伤和修复分子库
L3900
Compounds: 937
天然产物衍生物库
NY1000
Compounds: 4000
PPI抑制剂库
L9400
Compounds: 260
抑制剂库
L2000
Compounds: 7618
FDA上市及药典收录分子库
L1010
Compounds: 3158
中国药典收录天然产物库
L6800
Compounds: 2070
自噬库
L3200
Compounds: 1248
DNA损伤/修复库Plus
L3980
Compounds: 667
天然产物衍生物虚筛化合物库
L6030
Compounds: 0
表观遗传库
L1200
Compounds: 960
抗胰腺癌化合物库
L2192
Compounds: 2267
细胞因子抑制剂库
L3600
Compounds: 613
FDA 上市激酶抑制剂库
L1610
Compounds: 280
糖酵解化合物库
L2521
Compounds: 560
泛素化化合物库
L8600
Compounds: 214
铁死亡化合物库
L8700
Compounds: 800
口服活性化合物库
L9850
Compounds: 2484
5-羟色胺分子库
L2800
Compounds: 275
铜死亡化合物库
L8710
Compounds: 411
AMPK靶向分子库
L1120
Compounds: 64
血管生成库
L4800
Compounds: 1370
儿童药物库
L9210
Compounds: 1015
生物碱类天然产物库
L6110
Compounds: 468
凝血与抗凝化合物库
L7500
Compounds: 154
抗抑郁症化合物库
L9860
Compounds: 1181
神经信号分子库
L2600
Compounds: 2011
细胞凋亡化合物库
L9000
Compounds: 1796
抗癌天然产物库
L6700
Compounds: 1800
人内源代谢化合物库
L2500
Compounds: 1400
癌细胞分化化合物库
L2140
Compounds: 413
已知活性化合物库
L4010
Compounds: 20980
抗结直肠癌化合物库
L2194
Compounds: 1565
瑶药化合物库
L6200
Compounds: 225
脂代谢化合物库
L2510
Compounds: 496
多肽分子库
L9600
Compounds: 533
神经递质受体化合物库
L2610
Compounds: 1513
免疫/炎症分子化合物库
L4700
Compounds: 3483
植物来源化合物库
L4600
Compounds: 3076
高通量筛选天然产物库
L6000
Compounds: 4320
海洋天然产物库
L6400
Compounds: 94
肿瘤免疫治疗小分子化合物库
L2170
Compounds: 454
抗阿尔茨海默症化合物库
L9840
Compounds: 1040
大环化合物库
L9300
Compounds: 216
抗结直肠癌中药单体化合物库
L6740
Compounds: 386
特权片段注释化合物库-GPCR Family A
DC1010
Compounds: 0
h-TERT靶向化合物库
DP1300
Compounds: 0
Cat. No. Product Name Form Specificity Of Inhibition
C0003 Phosphatase Inhibitor Cocktail II (100× DMSO)

磷酸酶抑制剂 Cocktail II

Solution (100× in DMSO) Alkaline phosp<em><em>ha</em></em>tases, Ser/Thr phosp<em><em>ha</em></em>tases, Acid and PP1 and PP2A
C0002 Phosphatase Inhibitor Cocktail I (100× ddH2O)

磷酸酶抑制剂 Cocktail I

Solution (100× in ddH2O) Acid Phosp<em><em>ha</em></em>tase, Alkaline phosp<em><em>ha</em></em>tase, PTPs, ATPases
C0004 Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)

磷酸酶抑制剂 Cocktail III

2 Tube Solution (100×) Each Tube <em><em>ha</em></em>s different specificity of inhibition
C0001 Protease Inhibitor Cocktail

蛋白酶抑制剂 Cocktail

Solution (EDTA-Free,100× in DMSO) Serine proteases, Aminopeptidases, Cysteine proteases, Aspartic proteases
C0045 RIPA Lysis Buffer (Strong)

RIPA Lysis Buffer (Strong)

TargetMol 试剂盒

磷酸酶抑制剂 Cocktail II
C0003
磷酸酶抑制剂 Cocktail I
C0002
磷酸酶抑制剂 Cocktail III
C0004
蛋白酶抑制剂 Cocktail
C0001
RIPA Lysis Buffer (Strong)
C0045
Cat. No. Product Name Target Signaling Pathways
T38719L Influenza HA (110-119) acetate

Others Others
Influenza HA (110-119) acetate is the 110-119 fragment of influenza virus hemagglutinin that can stimulate Treg cells proliferation[1][2].
T38719 Influenza HA (110-119)

Influenza HA (110-119) is the 110-119 fragment of influenza virus hemagglutinin that can stimulate Treg cells proliferation.

化合物

Influenza HA (110-119) acetate
T38719L
synonym:
Target: Others
Influenza HA (110-119)
T38719
synonym:
Target: